Inventor

VASUDEVAN JAYASREE

US28 patents

⚠️ This page may combine multiple inventors who share the name “VASUDEVAN JAYASREE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

VASUDEVAN JAYASREE

ALLERGAN SALES INC

Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI

2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors

Tetrahdroquinolin-2-one 6 or 7-yl, tetrahdroquinilin-2-thione 6 or 7-yl pentadienoic acid and related derivatives having retinoid-like biological activity

Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI

Compounds having activity as inhibitors of cytochrome P450RAI

Compounds having activity as inhibitors of cytochrome P450RAI

Compounds having activity as inhibitors of cytochrome P450RAI

Compounds having activity as inhibitors of cytochrome P450RAI

Amines substituted with a dihydro-benzofuranyl or with a dihydro-isobenzofuranyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity

2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors

Compounds having activity as inhibitors of cytochrome P450RAI

Compounds having activity as inhibitors of cytochrome P450RAI

Compounds having activity as inhibitors of cytochrome P450RAI

Compounds having activity as inhibitors of cytochrome P450RAI

Compounds having activity as inhibitors of cytochrome P450RAI

Compounds having activity as inhibitors of cytochrome P450RAI

ALLERGAN INC

Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI

Dihydrobenzofuran and dihydrobenzothiophene 2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors

Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same

Methods for identifying inhibitors of cytochrome P450RAI

3,5-di-iso-propyl-heptatrienoic acid derivatives having serum glucose reducing activity

1-imidazolyl substituted tetrahydronaphthalene derivatives as inhibitors of eytochrome P450RAI

Methods for treating retinoid responsive disorders using selective inhibitors of CYP26A and CYP26B

4-[(8-ethynyl, 8-vinyl or 8-ethynyl-methyl)-6-chromanoyl]-benzoic and 2-[4-[(8-ethynyl, 8-vinyl or 8-ethynyl-methyl)-6-chromanoyl]-phenyl]-acetic acid, their esters and salts having cytochrome p450rai inhibitory activity

Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same

7-[(7-Alkoxy)-chrom-3-en-6-yl]-heptatrienoic acid and 7-[(3-alkoxy)-5,6-dihydronaphthalen-2-yl]-heptatrienoic acid derivatives having serum glucose reducing activity

Compounds having activity as inhibitors of cytochrome P450RAI

4-[(8-substituted)-6-chromanoyl]-and 4-[8-substituted)-chroman-6-YL-ethynyl]-benzoic and phenylacetic acids, their esters and salts having cytochrome P450RAI inhibitory activity